Advancing Therapy in Uncontrolled Basal Insulin (BI)-Treated Type 2 Diabetes (T2D): Subanalysis of the SoliMix Trial in Participants in Europe

被引：0
|
作者：
Cheng, Alice Y.
Mccrimmon, Rory J.
Fonseca, Vivian
Trescoli, Carlos
Haluzik, Martin
Seufert, Jochen
Alvarez, Agustina
Souhami, Elisabeth
Picard, Pascaline
Bonnemaire, Mireille
Rosenstock, Julio
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-748-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
748-P
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Advancing Therapy in Uncontrolled Basal Insulin (BI)-Treated Type 2 Diabetes (T2D): Subanalysis of the SoliMix Trial Outside Europe
    Fonseca, Vivian
    Rosenstock, Julio
    Cheng, Alice Y.
    Emral, Rifat
    Sauque-Reyna, Leobardo
    Mohan, Viswanathan
    Al Sifri, Saud N.
    Alvarez, Agustina
    Djaballah, Khier
    Picard, Pascaline
    Souhami, Elisabeth
    Mccrimmon, Rory J.
    [J]. DIABETES, 2021, 70
  • [2] Advancing Therapy in Uncontrolled Basal Insulin-Treated Type 2 Diabetes (T2D): Nocturnal Hypoglycemia in the SoliMix Trial
    Mccrimmon, Rory J.
    Cheng, Alice Y.
    Fonseca, Vivian
    Choza, Ricardo
    Alessa, Thamer
    Alvarez, Agustina
    Souhami, Elisabeth
    Boss, Anders H.
    Picard, Pascaline
    Rosenstock, Julio
    [J]. DIABETES, 2021, 70
  • [3] Advancing therapy in people with suboptimally controlled basal insulin-treated type 2 diabetes: Subanalysis of the SoliMix trial in participants in Latin American countries
    Frechtel, Gustavo
    Sauque-Reyna, Leobardo
    Choza-Romero, Ricardo
    Anguiano, Luis
    Melas-Melt, Lydie
    Sanudo-Maury, Maria Elena
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (09): : 2526 - 2534
  • [4] Advancing Therapy in Uncontrolled Basal Insulin-Treated Type 2 Diabetes (T2D): Better Clinical Outcomes with IGlarLixi vs. Premix 70/30 in the SoliMix Trial
    Rosenstock, Julio
    Emral, Rifat
    Sauque-Reyna, Leobardo
    Mohan, Viswanathan
    Trescoli, Carlos
    Al Sifri, Saud N.
    Lalic, Nebojsa
    Alvarez, Agustina
    Picard, Pascaline
    Demil, Nacima
    Bonnemaire, Mireille
    McCrimmon, Rory J.
    [J]. DIABETES, 2021, 70
  • [5] Advancing Therapy in Basal Insulin Users with Type 2 Diabetes (T2D): Hypoglycemia as a Function of HbA1c in the SoliMix Trial
    Mccrimmon, Rory J.
    Home, Philip
    Cheng, Alice Y.
    Giorgino, Francesco
    Fonseca, Vivian
    Souhami, Elisabeth
    Alvarez, Agustina
    Boss, Anders H.
    Melas-Melt, Lydie
    Rosenstock, Julio
    [J]. DIABETES, 2021, 70
  • [6] Impact of Hypoglycemia on Insulin Titration and Fasting Plasma Glucose in Basal Insulin-Treated Type 2 Diabetes: A Subanalysis of the SoliMix Trial
    Giorgino, Francesco
    Rosenstock, Julio
    Ritzel, Robert
    Deyneli, Oguzhan
    Alvarez, Agustina
    Souhami, Elisabeth
    Melas-Melt, Lydie
    McCrimmon, Rory J.
    [J]. DIABETES, 2022, 71
  • [7] Impact of hypoglycaemia on insulin titration and fasting plasma glucose in basal insulin-treated type 2 diabetes: a subanalysis of the SoliMix trial
    Ritzel, R.
    McCrimmon, R. J.
    Rosenstock, J.
    Deyneli, O.
    Alvarez, A.
    Souhami, E.
    Melas-Melt, L.
    Giorgino, F.
    [J]. DIABETOLOGIA, 2022, 65 (SUPPL 1) : S328 - S328
  • [8] Advancing Therapy in Basal Insulin-Treated Type 2 Diabetes: Exploratory Analysis of the SoliMix Trial by Baseline Age, Diabetes Duration, and Renal Function
    Home, Philip
    Rosenstock, Julio
    Giorgino, Francesco
    Bluher, Matthias
    Djaballah, Khier
    Pegelow, Katrin
    Melas-Melt, Lydie
    [J]. DIABETES, 2022, 71
  • [9] Improved Treatment Perceptions with IGlarLixi vs. Premix Insulin in Type 2 Diabetes (T2D) Uncontrolled on Basal Insulin (BI) plus Oral Antihyperglycemic Drugs (OADs): Patient-Reported Outcomes (PROs) of the SoliMix Trial
    Polonsky, William H.
    Mccrimmon, Rory J.
    Whitmire, Katherine H.
    Giorgino, Francesco
    Chen, Jung-Fu
    Nicholls, Charlie
    Lew, Elisheva
    Alvarez, Agustina
    Coudert, Mathieu
    Rosenstock, Julio
    [J]. DIABETES, 2021, 70
  • [10] Advancing Therapy in Basal Insulin-Treated Type 2 Diabetes: Exploratory Analysis of the SoliMix Trial by Baseline HbA1c, Insulin Dose, and BMI
    Home, Philip
    McCrimmon, Rory J.
    Rosenstock, Julio
    Bluher, Matthias
    Pegelow, Katrin
    Melas-Melt, Lydie
    Djaballah, Khier
    Giorgino, Francesco
    [J]. DIABETES, 2022, 71
12345